Rev. Soc. Esp. Dolor. 2022; 29(3): 187-191 / DOI: 10.20986/resed.2022.3997/2022
Gerardo Correa, Gerardo Correa
ABSTRACT
Scars can be associated with intense pain, limit patient functionality, and affect the quality of life of patients. In addition, painful scars can be associated to dysesthesias, hyperalgesia, and allodynia. The 5% lidocaine patch has shown efficacy as a topical treatment for pain relief in traumatic or post-surgical scars. In this paper, three cases of patients with painful scars who were successfully treated with 5% lidocaine patches, a therapeutic tool frequently indicated for the relief of neuropathic pain, are described.
RESUMEN
Las cicatrices pueden asociarse a dolor de gran intensidad, limitar la funcionalidad y afectar la calidad de vida de los pacientes. Además, las cicatrices dolorosas pueden asociarse a disestesias, hiperalgesia y alodinia. El parche de lidocaína al 5 % ha demostrado eficacia como tratamiento tópico para el alivio del dolor en cicatrices traumáticas o postquirúrgicas. En el presente trabajo se describen tres casos de pacientes con cicatrices dolorosas que fueron tratados exitosamente mediante parches de lidocaína al 5 %, una herramienta terapéutica indicada frecuentemente para el alivio del dolor neuropático.
Nuevo comentario
Comentarios
No comments in this article
Bibliografía
1. Ogawa R. The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago. Plast Reconstr Surg. 2022;149(1):79e-94e.
2. Gold MH, Berman B, Clementoni MT, Gauglitz GG, Nahai F, Murcia C. Updated international clinical recommendations on scar management: part 1--evaluating the evidence. Dermatol Surg. 2014;40(8):817-24.
3. Gold MH, McGuire M, Mustoe TA, Pusic A, Sachdev M, Waibel J, et al. Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment. Dermatol Surg. 2014;40(8):825-31.
4. Høimyr H, von Sperling ML, Rokkones KA, Stubhaug A, Finnerup K, Jensen TS, et al. Persistent pain after surgery for cutaneous melanoma. Clin J Pain. 2012;28(2):149-56.
5. Bijlard E, Uiterwaal L, Kouwenberg CA, Mureau MA, Hovius SE, Huygen FJ. A Systematic Review on the Prevalence, Etiology, and Pathophysiology of Intrinsic Pain in Dermal Scar Tissue. Pain Physician. 2017;20(2):1-13.
6. Maguire MF, Ravenscroft A, Beggs D, Duffy JP. A questionnaire study investigating the prevalence of the neuropathic component of chronic pain after thoracic surgery. Eur J Cardiothorac Surg. 2006;29(5):800-5.
7. Reddi D, Curran N. Chronic pain after surgery: pathophysiology, risk factors and prevention. Postgrad Med J. 2014;90(1062):222-7.
8. Dualé C, Ouchchane L, Schoeffler P; EDONIS Investigating Group, Dubray C. Neuropathic aspects of persistent postsurgical pain: a French multicenter survey with a 6-month prospective follow-up. J Pain. 2014;15(1):24.e1-24.e20.
9. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618-25.
10. Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, et al. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain Rep. 2021;6(1):e895.
11. Fearmonti RM, Bond JE, Erdmann D, Levin LS, Pizzo SV, Levinson H. The modified Patient and Observer Scar Assessment Scale: a novel approach to defining pathologic and nonpathologic scarring. Plast Reconstr Surg. 2011;127(1):242-7.
12. van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plast Reconstr Surg. 2005;116(2):514-22.
13. Rodríguez Castillo T, Sanguineti Montalva A, Moreno Baeza N, Carrillo Gonzalez K, Hasbún Nazar A, Lopez Nuñez S. Adaptación transcultural del cuestionario POSAS (Patient and Observer Scar Assessment) para valoración de cicatrices. Rev Cirugia. 2019;71(5).
14. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36.
15. Perez C, Galvez R, Huelbes S, Insausti J, Bouhassira D, Diaz S, et al. Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component. Health Qual Life Outcomes. 2007;5:66.
16. Mick G, Baron R, Correa-Illanes G, Hans G, Mayoral V, Frías X, et al. Is an easy and reliable diagnosis of localized neuropathic pain (LNP) possible in general practice? Development of a screening tool based on IASP criteria. Curr Med Res Opin. 2014;30(7):1357-66.
17. Mayoral V, Pérez-Hernández C, Muro I, Leal A, Villoria J, Esquivias A. Diagnostic accuracy of an identification tool for localized neuropathic pain based on the IASP criteria. Curr Med Res Opin. 2018;34(8):1465-73.
18. Causeret A, Lapègue F, Bruneau B, Dreano T, Ropars M, Guillin R. Painful Traumatic Neuromas in Subcutaneous Fat: Visibility and Morphologic Features With Ultrasound. J Ultrasound Med. 2019;38(9):2457-67.
19. Laing TA, Sierakowski A, Elliot D. Management of painful scar-tethered cutaneous nerves of the upper limb. Hand Surg Rehabil. 2017;36(3):208-14.
20. Correa-Illanes G, Roa R, Piñeros JL, Calderón W. Use of 5 % lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves. Local Reg Anesth. 2012;5:47-53.
21. Baron R, Allegri M, Correa-Illanes G, Hans G, Serpell M, Mick G, et al. The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use. Pain Ther. 2016;5(2):149-69.
22. Del Toro D, Dedhia R, Tollefson TT. Advances in scar management: prevention and management of hypertrophic scars and keloids. Curr Opin Otolaryngol Head Neck Surg. 2016;24(4):322-9.
23. Mick G, Correa-Illanes G. Topical pain management with the 5% lidocaine medicated plaster--a review. Curr Med Res Opin. 2012;28(6):937-51.
24. Hans G, Joukes E, Verhulst J, Vercauteren M. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases. Curr Med Res Opin. 2009;25(11):2737-43.
25. Correa-Illanes G, Calderón W, Roa R, Piñeros JL, Dote J, Medina D. Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster. Local Reg Anesth. 2010;3:77-83.
26. de León-Casasola OA, Mayoral V. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence. J Pain Res. 2016;9:67-79.
27. Macedo RDR, Santos JPGD, Lobato ES, Mendes JP, Ikemoto RY, Rodrigues LMR. Application of 5% Lidocaine Adhesive Patch in Painful Surgical Scars: Clinical Trial. Rev Bras Ortop (Sao Paulo). 2021;56(5):601-14.
28. Schug SA, Lavand'homme P, Barke A, Korwisi B, Rief W, Treede RD; IASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain. 2019;160(1):45-52.
29. WHO. International Statistical Classification of Diseases and Related Health Problems (ICD). 11th Revision (ICD-11) [Internet]. WHO; 2022 [acceso el 30 de mayor de 2022]. Disponible en: https://www.who.int/standards/classifications/classification-of-diseases